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Decoy peptide targeted to Toll-
IL-1R domain inhibits LPS and 
TLR4-active metabolite morphine-3 
glucuronide sensitization of 
sensory neurons
Yohance M. Allette1, Youngsook Kim2, Aaron L. Randolph2,3, Jared A. Smith1, Matthew S. 
Ripsch2,3 & Fletcher A. White2,3
Accumulating evidence indicates that Toll-like receptor (TLR) signaling adapter protein interactions 
with Toll/Interleukin-1 Receptor (TIR) domains present in sensory neurons may modulate neuropathic 
pain states. Following ligand interaction with TLRs, TIR serves to both initiate intracellular signaling and 
facilitate recruitment of signaling adapter proteins to the intracytoplasmic domain. Although TLR TIR 
is central to a number of TLR signaling cascades, its role in sensory neurons is poorly understood. In this 
study we investigated the degree to which TLR TIR decoy peptide modified to include a TAT sequence 
(Trans-Activator of Transcription gene in HIV; TAT-4BB) affected LPS-induced intracellular calcium flux 
and excitation in sensory neurons, and behavioral changes due to TLR4 active metabolite, morphine-
3-glucuronide (M3G) exposure in vivo. TAT-4BB inhibited LPS-induced calcium changes in a majority of 
sensory neurons and decreased LPS-dependent neuronal excitability in small diameter neurons. Acute 
systemic administration of the TAT-4BB reversed M3G-induced tactile allodynia in a dose-dependent 
manner but did not affect motor activity, anxiety or responses to noxious thermal stimulus. These data 
suggest that targeting TLR TIR domains may provide novel pharmacological targets to reduce or reverse 
TLR4-dependent pain behavior in the rodent.
Activation of Toll-like receptor 4 (TLR4) using lipopolysaccharide (LPS) is known to induce pro-inflammatory 
cytokine production by monocytes and macrophages. TLR4 is not restricted to immune cells as numerous pri-
mary afferent sensory neurons exhibit functional TLR4. Endogenous and exogenous TLR4 agonists including 
the opioid receptor-inactive morphine metabolite morphine-3-glucuronide (M3G) produce rapid increases in 
neuronal calcium flux synonymous with elevated states of excitability and potentiation of voltage-gated sodium 
current in nociceptive sensory neurons1–7.
Little is known regarding neuronal TLR4 signaling in rodent neurons. TLR4 is known to be comprised of 
an extracellular domain with multiple leucine-rich repeats, a single transmembrane helix, and an intracellular 
region approximately 150 amino acids in size composed primarily of the Toll/IL-1R (TIR) resistance domain8, 9. 
The four TIR-containing adapter proteins, myeloid differentiation primary response gene 88 (MyD88), TIR 
domain-containing adapter protein (TIRAP), TIR domain-containing adaptor inducing IFN- β (TRIF) and 
TRIF–related adaptor molecule (TRAM), are responsible for the propagation of signal to downstream targets in 
a number of cell types10–12. In monocytes, interaction of LPS with TLR4 elicits cellular signaling through either 
MyD88-dependent or MyD88-independent pathways.
The MyD88-dependent pathway, common to the TLR family of receptors, serves to activate NFκB and 
elicit production of tumor necrosis factor alpha (TNFα) and interleukin-1beta (IL-1β)13, 14. Demonstration of 
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the importance of these interactions is best illustrated by mice with a TLR4 point mutation in the MyD88 TIR 
domain which renders mice LPS-resistant15. MyD88 signaling in the nervous system is not limited to TLRs 
as the pro-inflammatory actions of interleukin-1 type 1 receptor ([IL1R1] also known as CD121a [Cluster of 
Differentiation 121a]) requires MyD88-mediated activation16 to signal the presence of ongoing tissue inflam-
mation17. In contrast, a MyD88-independent pathway is associated with only TLR3 and TLR4 and initiates the 
specific TRIF/interferon-β pathway18, 19.
Adapter recruitment by TIR-MyD88 may be important for governing the TLR response in the injured nervous 
system. Recent findings suggest that mice with a deficit in functional MyD8820–22 or a null mutation combination 
of both MyD88 and TRIF exhibit partial reversal of injury-induced behavioral hypersensitivity which was not 
observed in TRIF null mice21. Though these studies reveal the necessity of TLR signaling21, 22, the activation of 
DRG sensory neurons using LPS appears to be independent of TRIF23.
One manner in which to identify the importance of TLR protein-protein interactions in the peripheral nerv-
ous system is to target the structurally-conserved BB-loop dependent TIR-TIR signaling13, 24. Initial studies 
by Toshchakov and colleagues screened libraries of peptides which mapped the entire surface of TLR4 TIR24. 
Decoy peptides were then tested for their ability to bind to different portions of TLR4 TIR domain and inhibit 
LPS-induced production of cytokines using peritoneal macrophages derived from mice. Subsequent findings 
determined that the decoy peptide 4BB strongly binds to TLR4 TIR24, 25 and inhibited LPS-associated cytokine 
production in macrophages24.
Based on the ability of decoy peptides to interfere with LPS-induced proinflammatory cytokine produc-
tion by macrophages, we observed that 4BB decoy peptide modified to include TAT (TAT-4BB) could diminish 
LPS-induced changes in intracellular calcium [Ca2+]i and excitability in acutely dissociated sensory neurons. We 
further show that rapid induction of mechanical allodynia by the TLR4-active metabolite, M3G, could be inhib-
ited in the presence of TAT-4BB but basal pain response to thermal stimulus was unaffected.
Methods
Animals. A total of 46 pathogen-free adult Sprague-Dawley rats from Harlan Laboratories (average weight 
of 150–200 g) were randomly assigned to treatment groups used for the described experiments. A total of 16 
adult female pathogen-free C57BL/6J mice from Harlan Laboratories were used (average weight of 25–30 g). 
Experiments were designed to minimize animal discomfort and the amount of animals needed for statistical 
evaluation. All behavioral studies were conducted during the 12 hour light cycle; controlled animal housing was 
maintained at a temperature of 23 °C (with a deviation of 3 °C) with 12 hour light and dark cycles daily. Mice 
were housed in groups by littermates. All animals were supplied with standard rodent chow and autoclaved tap 
water. The Institutional Animal Care and Use Committee (IACUC) of the Indiana University School of Medicine 
approved all disclosed experiments per protocol #10492. Animal procedures adhered to guidelines outlined 
within the Guide for and Care and Use of Laboratory Animals of the National Institutes of Health, with ethi-
cal guidelines outlined by the International Association for the Study of Pain. All behavioral data analysis was 
blinded.
Reagents. For each experiment, all reagents were prepared immediately in buffer prior to the procedure. 
Biologically reactive O5:55 serotype lipopolysaccharide (LPS) from Sigma (St. Louis, MO) was reconstituted 
in deionized water. NIH/NIDA Drug Supply Program provided morphine-3-β-D-glucoronide (M3G). Acute 
dissociation culture was media made of DMEM, Ham’s F-12 mixture, N2 (Life Technologies Corp.), penicillin 
(100 μg/mL), streptomycin (100 U/mL), and supplemented with 10% fetal bovine serum. The 4BB decoy peptide 
sequence (LHYRDFIPGVAIAA) was modified to include the TAT transduction domain of human immuno-
deficiency virus-1 segment (YGRKKRRQRRR) in order to increase membrane permeability in the rodent and 
neuronal cell cultures26. Peptide order was the TAT peptide sequence followed by the 4BB peptide sequence. A 
control peptide with TAT modification used a scrambled amino acid sequence (SLHGRGDPMEAFII)24. Tissue 
and cell distribution studies utilized fluorescent FITC-labeled TAT peptide alone or in conjunction with the 4BB 
peptide. All peptide preparations were diluted in saline solution. For intraperitoneal injections, a concentration 
of 10 mg/kg was used for all 4BB preparations. The in vitro applications of FITC-TAT-4BB used a concentration 
of 15 μM. Vehicle controls consisted of saline for all experiments. All peptides used for outlined experiments were 
created by GenScript utilizing their peptide synthesis service.
Tissue processing for FITC-TAT-4BB tissue. Animals were injected with 10 mg/kg FITC-TAT-4BB and 
sacrificed 15 minutes later. The animals were euthanized and perfused transcardially with a saline solution fol-
lowed by 4% paraformaldehyde fixative. The fixed tissue was cryoprotected with 30% sucrose then sectioned 
via the Leica Biosystems 3050 research cryostat (Buffalo Grove, IL) at a thickness of 15 μm. Before imaging, 
slides were stained with 4′ 6-diamidino-2-phenylindole (DAPI) for an exposure time of 5 minutes. An intensified 
charged coupled device camera (CoolSnap HQ2, Photometrics; Tucson AZ) connected to a Nikon microscope 
using Nikon Elements Software (Nikon Eclipse Ti, Nikon Instruments Incorporated, Melville, NY) was used for 
image acquisition.
Preparation of acutely dissociated dorsal root ganglion neuron. Dorsal root ganglia L4 – L6 were 
used as the source for a nociceptive primary cell culture population. The DRG tissues were dissected and collected 
immediately post mortem27. The collected samples were initially dissociated using a solution of DMEM, neutral 
protease, and collagenase (Worthington Biochemical) at a temperature of 37 °C on a rocker at a low setting for 
40 minutes. The tissue was further dissociated by mechanical trituration and plated on poly-L lysine and laminin 
coated coverslips (BD Biosciences) in a culture media of 1 mg/mL bovine serum albumin and trypsin inhibitor 
(Worthington Biochemical). Following plating, cells were incubated for 2–3 hours, and then another 1 mL of 
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culture media was adding to each well. The cells were then incubated overnight for 12–15 hours at a temperature 
of 37 °C with 5% CO2 to improve adhesion to coverslips prior to experimentation. Some sensory neurons were 
exposed to FITC-TAT-4BB for 15 minutes using 15 μM solution.
Ca2+ imaging in acutely dissociated dorsal root ganglion neurons. Dissociated DRG cells were 
exposed to Fura 2-AM at 3 mM (Invitrogen) for at least 25 minutes at room temperature. Intracellular calcium 
changes were monitored in a balanced salt solution (BSS). BSS was composed of NaCl 140 mM, Hepes 10 mM, 
glucose 10 mM, KCl 5 mM, CaCl2 2 mM, and MgCl2 1 mM. Following Fura 2-AM exposure, coverslips were rinsed 
a total of three times in BSS. The changes in intracellular calcium (Ca2+) were observed and recorded with digital 
video microflurometry using an intensified CCD camera coupled to a Nikon Eclipse TE2000-U microscope with 
Nikon Elements® software. Using a 150 W xenon arc lamp, coverslips were illuminated – the 340/380 nm excita-
tion wavelengths of Fura 2-AM were selected by Lambda DG5 plus illumination system (Sutter Instruments, 
Novato CA). Prior to treatment administration, sterile BSS was applied, and any cells showing a response of any 
kind to buffer alone were excluded from data collection.
The calcium imaging experiments were modified from the previous application (Allette et al.6). A minimum of 
three minutes between treatments allowed to make sure that the signal re-established to the baseline level imme-
diately prior to the treatment. Following a baseline measurement of intracellular calcium changes for 1 minute, 
Ca2+ influx was initiated by the addition of either LPS 1–2 μg/mL or M3G 3 μM. Both LPS and M3G treatments 
were diluted in Tyrode’s solution. Cells were first exposed to TAT-4BB at a concentration of 15 μM before admin-
istration of the second LPS treatment.
All traces recorded from calcium imaging were independently analyzed by two different researchers. The pre-
set criteria for data collection included a 340 nm/380 nm fluorescence ratio that must exceed the baseline value 
preceding treatment administration by 10%, and that two independent data analysts agreed on all recorded cell 
responses used in cell counts.
Electrophysiology. Using the inverted microscope (Nikon Eclipse Ti; Nikon Instruments Inc. Melville, NY) 
sharp electrode intracellular recordings from primary afferent neurons were collected at room temperature. The 
primary afferent neurons were used 12–18 hours following acute dissociation. Micropiptettes for recording were 
made on a Flaming/Brown micropipette puller (P-98 Sutter Instruments) and made of borosilicate glass (Word 
Precision Instruments; Sarasota FL). Micropipettes were filled with a 1.0 M KCl solution (40–80 MΩ imped-
ance) prior to recording. To bridge-balance the micropipette resistance, a current injection of −0.1 nA was used. 
A micromanipulator (Newport Corporation; Irvine, CA) was used for exact positioning of the micropipettes. 
The recording chamber was perfused with a saline solution (NaCL 120 mM, Hepes 10 mM, glucose 10 mM, KCl 
3 mM, CaCl2 1 mM, MgCl2 1 mM).
All neurons were classified by soma diameter (large ≥45 μm, medium 30–45 μm, small ≤30 μm). Only neu-
rons exhibiting a resting membrane potential greater that −45mV were accepted for study. All neurons used 
in study were measured for a 1 minute period under without any external treatments or stimulus. Both small 
and medium sized neurons were measured for neuronal excitability by injection of current pulses directly 
into the soma at intervals of 30 seconds, with injections consisting of 1 second pulses (Due et al.5). Current 
was adjusted accordingly to ensure firing of 1–2 action potentials per current injection in baseline conditions. 
Electrophysiological recordings utilized continuous current-clamp in bridge mode, and used an AxoClamp-2B 
amplifier. Data were stored through the Digidata 1322 A interface. Data analysis was completed offline using the 
pClamp 9 software from Axon Instruments.
Following 3 control current injections, LPS at 1–2 μg/mL was applied and current injections continued every 
30 seconds. Exposure to the decoy peptide at a concentration of 15 μM prior to application of LPS at 1–2 μg/mL 
was experiment-dependent. Neuronal excitability was measured as the number of action potentials elicited per 
current pulse both prior to and following the application of LPS. In the case of increased neuronal excitability 
following LPS administration, either the decoy peptide or vehicle treatment was applied to determine the reversal 
of the LPS-driven neuronal excitation.
Mechanical Withdrawal Threshold Measurements. A minimum 2 day period was utilized for the 
habituation of all animals to the behavioral testing chambers. Rodents were randomly assigned to either the vehi-
cle or M3G treatment groups. Von Frey filaments measuring 200 μm in diameter were used to elicit responses to 
mechanical indentation of the plantar aspect of the animal hindpaw28. At designated loci on the plantar surface 
force was applied using filaments (10, 20, 40, 60, 80, 120 mN). Each stimulus lasted approximately 1 second and 
had a 10–15 second intermission between applications. The incidence of foot withdrawal was recorded as a per-
centage of six stimuli and the percentage of requisite withdrawal; results were subsequently plotted as a function 
of force. Optimal TAT-4BB dosing was first determined using small pilot groups, with concentrations of 0.1, 1, 
and 10 mg/kg. Animals were assessed both prior to treatment, and 1 and 4 hours status post treatment. Individual 
testers blinded to decoy peptides completed all behavioral assessments and data collection. A total of five inde-
pendent animal groups consisting of 6–8 animals, were used for behavior experiments.
Foot Withdrawal to Plantar Thermal Stimulus. The Hargreaves’ plantar test apparatus (Ugo Basile; 
Varese, Italy) was used to assess the effects of nocifensive behavior of uninjured animals following noxious ther-
mal stimulation in the absence and presence of the decoy peptides. The apparatus has a glass floor of 2mm thick-
ness kept at a temperature of 22.5–23.5 °C, and contains a mobile infared heat generator. The heat generator 
aperture was focused on the animal hindpaw through the glass floor. The latency to withdrawal (i.e. reaction 
time) was recorded following the activation of the heat generator. If a shortening of the withdrawal latency was 
observed, this was considered thermal hyperalgesia.
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Following animal habituation to the apparatus and environment, measurements of withdrawal latency were 
repeated a total of 4 times at 5 minute intervals on each paw. The setting of the heat generator was at IR = 70, and 
the initial pair of data for each paw was not used in data analysis; only the average of the three remaining data 
pairs were utilized. A total of three naïve animals were assessed with the decoy peptide.
Open-field test as a measure of anxiety-associated behavior. Female mice were used for behavioral 
analyses. All behavioral testing performed in female mice was completed prior to the start of the estrous cycle. 
Prior to any behavioral testing, the mice were brought into the procedure room and allowed to habituate to the 
room for 30 minutes. Animal numbers per group for behavioral tests are indicated in figures. All behavioral 
analyses were done by observers who were blinded to drug condition. The open-field arena covered an area of 
40 cm × 40 cm, with 40 cm high walls. The outside walls of the chamber were opaque. During this one-time test, 
an animal was placed in the empty plexiglass arena and allowed to explore for 10 minutes. The position of the 
mouse was tracked using AnyMaze (Stoelting, Wood Dale, IL). Distance traveled, average speed, time spent in 
inner ring and total time immobile were analyzed per 10-minute video.
Statistics. All enclosed data are presented as group mean ± SEM following statistical analysis using GraphPad 
Software (LaJolla, CA); a p-value of <0.05 was set as the threshold for statistical significance. All baseline data for 
tactile tests were recorded prior to experimental procedures (i.e. drug and vehicle dosing to animals). Repeated 
measures of ANOVA (analyses of variance) followed by post-hoc Tukey’s multiple comparison test were used to 
assess data from each treatment group compared to respective baseline values. Both tactile and thermal threshold 
time course were analyzed, and plotted as the mean ± SEM compared to time after treatment. Open field experi-
ment data was analyzed by two-tailed unpaired Student’s t-test. The chi-square test with Yates correction was used 
for assessing the statistical significance of the differences in calcium response for both capsaicin sensitive and 
non-capsaicin sensitive neurons.
Results
Distribution of the cell-penetrating protein trans-activator protein (TAT) in vivo, and TLR4/TIR-
specific decoy peptide 4BB in vitro. Recent studies targeting the surface-exposed segments of TLR4 TIR 
domain proteins with decoy peptides demonstrate effective inhibition of LPS-mediated macrophage signaling 
using a cell-permeating protein in the form of the Antennapedia homeodomain sequence24. Inclusion of the 
Antennapedia homeodomain allows peptides to cross the blood brain barrier but the tagged peptide is selec-
tively taken up by a subpopulation of neurons, suggesting a restricted penetrance of some cell layers or tissue29. 
Another cell-penetrating protein, HIV trans-activator protein (TAT) has also proven to be effective in trans-
porting large and small molecules across cellular membranes into a larger population of neurons26, 30. To assay 
the degree to which TAT efficiently distributes to cells present in tissues of interest, we intraperitoneally injected 
TAT-4BB labelled at the N-terminus with FITC (FITC-TAT-4BB) into rats. Systemic exposure to FITC-TAT-4BB 
produced fluorescent label in almost all neurons in the trigeminal and dorsal root ganglia (Fig. 1A and C), some 
Figure 1. Cryosections of dorsal root ganglion (DRG), trigeminal ganglion (TRG), ventral spinal cord and 
colon in the rat thirty minutes after intraperitoneal injection of FITC-TAT-4BB. (A) FITC-TAT-4BB present 
in a number of primary afferent sensory neurons in lumbar DRG (green arrows). (B) FITC-TAT-4BB present 
in a number of motor neurons in ventral spinal cord (green arrows). (C) FITC-TAT-4BB present in a number 
of primary afferent sensory neurons in TRG (green arrows). (D) FITC-TAT-4BB present in a number of 
presumptive immune cells based on size and location (green arrows). Nuclei of all cells are stained with DAPI 
(A1, B1, C1, D1 blue). Scale bar is 100 μm.
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ventral motor neurons in the spinal cord (Fig. 1B) and numerous non-neuronal cells in the gastrointestinal tissue 
(Fig. 1D).Distribution of FITC-TAT-4BB following in vitro exposure produced robust penetration of sensory 
neurons (based on morphology and diameter) but was absent in non-neuronal cells (Fig. 2).
TLR4/TIR decoy peptides decrease M3G and LPS-induced Ca2+ mobilization in dissociated sen-
sory neurons. We next sought to determine whether LPS and M3G can directly excite DRG neurons by 
examining their ability to elicit calcium signals. Activation of sensory neurons using LPS or the TLR4-active 
morphine metabolite, M3G, results in detectable changes in cytoplasmic calcium ([Ca2+]i)6, 31, 32 and the use of a 
TLR4 small molecule inhibitor effectively blocks [Ca2+]i in these same sensory neurons4, 6. Herein, cultured neu-
rons rapidly responded to LPS and to M3G, as indicated by increased intracellular calcium levels, suggesting that 
DRG neurons express TLR4. The order of exposure to the LPS followed by M3G induced more responses than 
M3G followed by LPS (Table 1).
To determine the effect of TAT-4BB in the presence of LPS, we first demonstrated that none of the cells which 
were affected by the presence of the TAT-control peptide (n = 4 animals; n = 25 cells) (Fig. 3A). LPS responsive 
cells were then exposed to TAT-control peptide or TAT-4BB (15 μM) followed by a second exposure to LPS. A 
large number of LPS-responsive neurons (71%) were desensitized to the second exposure of LPS following TAT-
4BB (n = 4 animals; 38 total cells) (Fig. 3B). Previous observations indicate that LPS and M3G exposure produce 
increases in [Ca2+]i in the similar neuron populations and can be inhibited by a small molecule inhibitor of TLR4 
(Due et al.4). Based on these observations, we demonstrate that most M3G responsive sensory neurons also 
respond to LPS exposure (89%; n = 9 cells) (Fig. 3C).
Figure 2. FITC-TAT-4BB predominately accumulates in acutely dissociated neurons (A, green arrows). Nuclei 
of all cells are stained with DAPI (B, blue). Bright field of representative acutely dissociated cells (C). Merged 
images are shown in (D). Scale bar is 20 μm.
Order of 
Protein 
Tested
#Neuronal 
responses/total 
#Of neurons, (%)
#Neuronal 
responses to both 
LPS and M3G/total 
#Of neurons, (%)
#Animals 
per assay
(1) LPS 26 of 58 (44%) 4
(2) M3G 10 of 58 (17%) 38.5%* 4
(1) M3G 9 of 64 (14%) 4
(2) LPS 19 of 64 (29%) 89%* 4
Table 1. Calcium imaging of DRG neurons. *p < 0.05, Chi-square with Yates correction.
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TAT-4BB decoy peptide diminishes inward current facilitation in nociceptive neurons. TLR4 
agonists such as LPS have been shown to elicit inward current in nociceptive sensory neurons and increase the 
excitability of sensory neurons1, 3, 4. These agonists also elicit activation of TLR4-mediated excitation in nocicep-
tive neurons increases density in a number of voltage-gated sodium currents4, 5. To determine the degree to which 
the decoy peptide TAT-4BB inhibited LPS-induced neuronal excitation, we examined neuronal response using 
sharp electrodes in current clamp mode.
Repeated current pulse combined with LPS administration produced a significant increase in the excitability 
of small diameter neurons when compared to baseline levels, though less than 27% of neurons responded to LPS 
(n = 13 of 49 cells). We also observed 1.6 ± 0.2 APs in cells under control conditions compared to 4.8 ± 0.6 APs in 
cells subjected to LPS (cell n = 9 cells; animal n = 5) (Fig. 4A). Subsequent treatment with TAT-4BB completely 
blocked LPS-dependent sensitization in all sensory neurons that responded to LPS (1.2 ± 0.2 APs for TAT-4BB, 
n = 9 cells; F = 41.82, p < 0.05; Dunnett’s multiple comparison test, p < 0.05) (Fig. 4B). Exposure of LPS respon-
sive neurons to control peptide did not alter LPS-induced neuronal sensitization (data not shown). These studies 
show that in addition to TAT-4BB reducing LPS-induced [Ca2+]i in sensory neurons, TAT-4BB suppresses sensi-
tization of sensory neurons in the presence of the TLR4 ligand LPS.
Pretreatment of rodents with TAT-4BB prevents the rapid induction of tactile hyperalgesia due 
to systemic morphine-3-glucuronide administration. Systemic M3G administration produces rapid 
induction of mechanical allodynia but not thermal hyperalgesia in rodents through a TLR4 dependent mecha-
nism4. The poor permeability of M3G into brain tissue following intravenous bolus suggests that the behavioral 
Figure 3. Lipopolysaccharide (LPS) and morphine-3-glucuronide (M3G) increases in calcium signaling in 
cultured dorsal root ganglion (DRG) neurons can be prevented by exposure to TAT-4BB. Ca2+ imaging was 
performed on acutely dissociated adult sensory neurons using the ratiometric Ca2+- sensitive dye, FURA-2AM. 
(A) Selected trace depicts neuron response to LPS followed by wash out of the well with room-temperature bath 
solution. Cells were then exposed to control scramble peptide followed by LPS exposure. Control peptide did 
not alter LPS-induced event. (B) Selected trace depicts neuron response to LPS followed by wash out of the well 
with room-temperature bath solution. Cells were then exposed to TAT-4BB peptide followed by LPS exposure. 
Second LPS exposure failed to elicit change in Ca2+-flux. (C) Selected trace depicts neuron response to M3G 
followed by wash out with bath solution. Cells were then exposed to LPS which elicited a second Ca2+-flux.
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effects of the metabolite are due to drug interactions in the peripheral compartment33, 34. Based on the presump-
tive peripheral effects of intraperitoneal injection of M3G on paw withdrawal threshold (32.4 ± 3.4 mN; n = 16), 
we observe that pretreatment with TAT-4BB (10 mg/kg, i.p.) effectively eliminates changes in paw withdrawal 
threshold to tactile stimulus when compared with control peptide (10 mg/kg, i.p.; n = 8 per dose, 60.14 ± 4.37 
mN; F = 12.81, p < 0.05) (Fig. 5).
TAT-4BB decoy peptide did not alter open-field behavior. As a measure of possible off-target effects 
of the decoy peptide we investigated the possible effects of TAT-4BB on anxiety-like behavior in mice. Anxiety 
in mice reflects a conflict between risk and reward35 and can be evaluated in rodents using an accepted test of 
anxiety-associated behavior, the open-field test (OFT). Rodents with anxiety behavior spend less time exploring 
the center of the chamber and travel shorter distances36, 37. Mice receiving single injections of vehicle (n = 5) 
or TAT-4BB (n = 8) did not show differences in general locomotor associated behaviors during a either a 5 or 
10 minute period of time (distance traveled, t(10) = 0.2791, p = 0.78; average speed t(10) = 0.2681, p = 0.7941) in 
the open-field. In addition, TAT-4BB treated rodents did not show a change in the total time immobile (center 
time, t(10) = 0.4625, p = 0.6536) or a preference for spending more time in the inner ring zone of the open-field or 
compared to vehicle-treated controls (inner ring time, t(10) = 0.6793, p = 0.5124) (Fig. 6).
Discussion
Recruitment of the TLR adapter proteins are likely critical to the first intracellular events following neuronal 
exposure to LPS. Assembly of TLR4 signaling adapter proteins present in nociceptive neurons is followed by 
rapid changes in action potential discharge, voltage-gated sodium currents, intracellular calcium and activity 
dependent release of neuropeptides3, 4, 38. Though several additional mechanisms may be involved with the neu-
ronal TLR4-mediated events, we demonstrate for the first time that interruption of the TLR TIR-dependent sig-
nal transduction using TAT-4BB can inhibit an important upstream pathway for both LPS and M3G-mediated 
changes in neuronal signaling events. In addition, TAT-4BB can prevent M3G-induced tactile allodynia in 
rodents.
Ligand binding to TLR4 present on macrophages and microglial cells leads to activation of nuclear factor 
κB (NFκB) where it initiates the transcription of genes encoding inflammatory cytokines. The activation of this 
receptor and downstream TLR TIR cell signaling leads to cytokine and chemokine release, though dependent 
on increases in Ca2+, does not produce an immediate increase in [Ca2+]i39. Unlike the relatively slow responses 
observed in monocytes and microglial cells, activation of neuronal TLR responses are rapid and may contribute 
to potentiation of neuronal excitability through nonselective cation channels such as TRPV1 or TRPA11, 20, 40, 41, 
voltage-gated ion channel events4, 42–44 or TNF-α mediated events45. Similar observations have been docu-
mented with another MyD88-dependent cytokine, IL-1β. IL-1β neuronal stimulation can rapidly activate both 
post-translational changes of proteins and tetrodotoxin-resistant currents in nociceptive cells17.
The ability of TLR4 active agonists to elicit rapid intracellular calcium mobilization in sensory neurons pre-
dicts that these cells may convey mechanical modalities independent of inflammation states46. Though not dis-
tinguished herein, transactivation of the TRPV1 channel through TLR4 stimulation has been shown a potential 
mechanism of nociceptive response1. TRPV1-bearing cells may not be only capable of sensing thermal changes as 
a number of these neurons co-express TRPA147, 48, but also may be cross-sensitized by the presence of TRPA1 ago-
nists49. Similar TLR agonist-dependent actions have been described for bacterial N-formylated peptides and the 
pore-forming toxin α-haemolysin reflecting neuronal TLR2 signaling44. The degree to which TAT-4BB influences 
Figure 4. Lipopolysaccharide (LPS) increases in nociceptive neuron excitability is reversed by TAT-4BB. 
(A) Current clamp recordings were performed on small-to-medium (>30 μm–>40 μm) diameter lumbar 
4–5 dorsal root ganglia (DRG) neurons from naive rats. Firing of 1–2 action potentials was elicited by a 
1 second depolarizing current injection (ranging from 0.1 to 2.0 nA depending on the cell) every 30 seconds. 
Representative recordings demonstrating that application of LPS and the subsequent increase in elicited action 
potentials in DRG sensory neurons can be reversed by administration of the 4BB MyD88 decoy peptide (n = 9 
cells). (B) Group data showing that LPS caused a significant increase in DRG AP firing which is reversed by 
addition of TAT-4BB. Values are based on an n = 9 cells ∗ = p < 0.01.
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neuronal TLR2 is unknown but mutations within the BB loop and associated TLR TIR domain is critical for 
inhibiting TLR2 activation in Staphylococcus aureus lipoteichoic acid- and Pam3CSK4-treated macrophages50. 
Though sensory neurons are known to exhibit functional receptors for TLR5 and TLR741, 51, 52, less is known 
regarding the role of the BB-loop of the TIR domain for TLR553 or TLR7 signaling54.
There is a distinct possibility that ion channels may be associated with TLR4 activation including voltage-gated 
sodium channels. It is known that TLR4 agonists such as the M3G elicits a substantial increase in the current density 
for voltage-gated sodium channels (NaV), NaV1.6, NaV1.7 and NaV1.9, but not NaV1.84. Increased firing of these 
channels may contribute to opioid-induced tactile allodynia4. These opioid metabolite-induced changes in neuronal 
excitability can be pharmacologically inhibited by the state-dependent sodium channel blocker, carbamazepine5.
Although there is some question regarding the ability of M3G to interact with MD2 using in silico 
approaches55 or to elicit macrophage activation in vitro56, it appears that M3G elicits consistent TLR4 activation 
and pro-inflammatory cytokine production in morphine-treated mice34. TLR4 activation effects in non-neuronal 
Figure 5. Effects of cell-permeable TAT-4BB decoy peptide on thermal sensitivity and tactile allodynia. (A) TAT-
4BB and TAT-CP was tested for the ability to alter nocifensive behavior in naïve rats. (B) TAT-4BB was tested for 
the ability to prevent sensitivity to tactile stimulus one hour after M3G administration. TAT-4BB potently affected 
behavioral hypersensitivity at 10 mg/kg but not 1 mg/kg. Values are the mean ± SEM of two groups of 8 rats per 
time point. (∗ = p < 0.05 TAT-4BB in combination with M3G rats compared to M3G treatment alone).
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cell types may also depend on NaV channels. Most notably, phagocytic activity, migrational activity, and sys-
temic inflammatory responses by macrophages and microglia can be modulated by the activity of NaV1.6 but 
not Nav1.7, Nav1.8, or Nav1.957, 58. However, the sodium ion channel properties and subsequent downstream 
signaling through p38/mitogen-activated protein kinases or nuclear factor κB (NFκB) necessary for these proin-
flammatory events are largely unknown59, 60.
Conclusion
In summary, our experiments suggest a role of TLR-TIR signaling in nociceptor sensitization following LPS 
or M3G. This nociceptor sensitization can be suppressed using TAT-4BB in primary afferent sensory neurons. 
Further research is required to understand the relative importance of the TLR TIR signaling downstream of the 
receptor activation in primary afferent sensory neurons and the potential influence on neuronal ion channels.
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Figure 6. TAT-4BB does not produce deficits in anxiety-like behavior in female mice using open field testing 
(OFT). (A) Representative activity traces for rodents in the OFT following TAT-4BB administration. (B) Total 
time spent in the inner ring zone. (C) Total time immobile (D) Average speed (E) Total distance traveled. Data 
in both vehicle (n = 5) and decoy peptide (n = 8) reflects means and SEM.
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